Autor: |
Tavera-Mendoza LE; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215., Westerling T; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215., Libby E; Santa Fe Institute, Santa Fe, NM 87501., Marusyk A; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, University of South Florida, Tampa, FL 33612., Cato L; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215., Cassani R; Institut National de la Recherche Scientifique, Centre Énergie, Matériaux, Télécommunications, University of Quebec, Montreal, QC H5A 1K6, Canada., Cameron LA; Confocal and Light Microscopy Core, Dana-Farber Cancer Institute, Boston, MA 02215., Ficarro SB; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02215., Marto JA; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02215., Klawitter J; Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045., Brown M; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215; myles_brown@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215. |